Ornowska M, Wittmann J, Blitz S, Wong H, et al. 4% Tetrasodium EDTA to Prevent Central Venous Access Device-Associated Complications: A Randomized Clinical Trial. JAMA 2026 May 18:e266025. doi: 10.1001/jama.2026.6025.
PMID: 42150112